Insignificant disease among men with intermediate-risk prostate cancer

被引：0
|
作者：
Sung Kyu Hong
Emily Vertosick
Daniel D. Sjoberg
Peter T. Scardino
James A. Eastham
机构：
[1] Memorial Sloan-Kettering Cancer Center,Urology Service, Department of Surgery
[2] Seoul National University Bundang Hospital,Department of Urology
[3] Memorial Sloan-Kettering Cancer Center,Department of Epidemiology and Biostatistics
[4] Cornell University,Department of Urology, Weill Cornell Medical College
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
Prostate; Prostatic neoplasms; Insignificant; Intermediate risk; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1417 / 1421
页数：4
相关论文
共 50 条
  • [31] Re: Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-risk Prostate Cancer
    Gandaglia, Giorgio
    Briganti, Alberto
    Montorsi, Francesco
    EUROPEAN UROLOGY, 2016, 69 (02) : 370 - 370
  • [32] Heterogeneity in early oncologic outcomes among men with NCCN intermediate-risk prostate cancer treated with radical prostatectomy.
    Ghabili, Kamyar
    Nguyen, Kevin
    Lu, Amanda
    Hsiang, Walter
    Shuch, Brian M.
    Leapman, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [33] Assessing Potential Cardiovascular Risk Against the Benefits of Hormonal Therapy in Men With Intermediate-Risk Prostate Cancer
    Lester-Coll, N. H.
    Johnson, S.
    Magnuson, W. J.
    Yu, J. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S140 - S140
  • [34] To Treat or Not to Treat Men With Low-risk or Intermediate-risk Prostate Cancer-Weighing the Evidence
    Halabi, Susan
    Carthon, Bradley C.
    Kelly, Wm Kevin
    JAMA ONCOLOGY, 2022, 8 (08) : 1137 - 1138
  • [35] Improving the Stratification of Patients With Intermediate-risk Prostate Cancer
    Stolzenbach, Lara Franziska
    Nocera, Luigi
    Colla-Ruvolo, Claudia
    Tian, Zhe
    Knipper, Sophie
    Maurer, Tobias
    Tilki, Derya
    Graefen, Markus
    Karakiewicz, Pierre I.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (02) : E120 - E128
  • [36] Management of low- and intermediate-risk prostate cancer
    Henk van der Poel
    Laurence Klotz
    Christian G. Stief
    World Journal of Urology, 2015, 33 : 905 - 906
  • [37] Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with radiation therapy
    Nanda, A.
    Chen, M.
    Moran, B. J.
    Braccioforte, M. H.
    Dosoretz, D.
    Salenius, S.
    Katin, M.
    Ross, R.
    D'Amico, A. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [38] Personalization of Treatment Intensity for Intermediate-Risk Prostate Cancer
    Zumsteg, Zachary S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (03): : 744 - 746
  • [39] Management of low- and intermediate-risk prostate cancer
    van der Poel, Henk
    Klotz, Laurence
    Stief, Christian G.
    WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 905 - 906
  • [40] Testosterone Replacement in a Man with Intermediate-risk Prostate Cancer
    Morales, Alvaro
    EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 319 - 320
12345